enVVeno Medical (NVNO) Invested Capital (2017 - 2026)

enVVeno Medical has reported Invested Capital for 10 years, with the latest figure at $23.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 38.01% year-over-year to $23.7 million; the trailing twelve-month figure through Mar 2026 stood at $23.7 million (down 38.01% YoY), and the FY2025 full-year result was $27.1 million, down 35.65% from the prior year.
• Invested Capital for Q1 2026 stood at $23.7 million, down from $27.1 million in the prior quarter.
• The five-year high for Invested Capital was $51.3 million in Q1 2022, with the low at $23.7 million in Q1 2026.
• Average Invested Capital over 5 years is $37.4 million, with a median of $38.4 million recorded in 2024.
• Year-over-year, Invested Capital tumbled 41.61% in 2023 and surged 90.13% in 2024.
• Tracing NVNO's Invested Capital over 5 years: stood at $38.7 million in 2022, then grew by 19.29% to $46.2 million in 2023, then declined by 8.75% to $42.2 million in 2024, then slumped by 35.65% to $27.1 million in 2025, then dropped by 12.47% to $23.7 million in 2026.
• The last three Invested Capital figures came in at $23.7 million (Q1 2026), $27.1 million (Q4 2025), and $29.4 million (Q3 2025), per Business Quant data.

Peer Comparison